Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices 67767 

TABLE 1—RECIPIENTS AND SUPPLEMENT AWARD AMOUNTS

Grant No. Award recipient name City, state Award amount 

U1IMC45814 .................................................. Children’s National Medical Center .................................................... MD $400,000 

U1IMC43532 .................................................. University Hospitals Cleveland Medical Center ................................. OH 400,000 

Amount of Non-Competitive 

Award(s): Two awards at $400,000 per 

grant recipient totaling $800,000. 

Project Period: September 1, 2023, to 

August 31, 2024. 

Assistance Listing (CFDA) Number: 

93.110. 

Award Instrument: Supplement for 

RPPN support services. 

Justification: Approximately $400,000 

in supplemental funding has been 

awarded to each RPPN cooperative 

agreement recipient to increase 

activities to coordinate among the 

nation’s pediatric hospitals and their 

communities to prepare for and respond 

to global health threats and coordinate 

research-informed responses to future 

pandemics. Projects approved by HRSA 

under this supplement are to be 

performed from the date of award 

through August 31, 2024. 

Carole Johnson, 

Administrator. 

[FR Doc. 2023–21670 Filed 9–29–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Charter Renewal for the Advisory 

Committee on Infant and Maternal 

Mortality 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Department of Health and Human 

Services is giving notice that the 

Advisory Committee on Infant and 

Maternal Mortality (ACIMM or 

Committee) is renewed. The effective 

date of the charter renewal is September 

30, 2023. 

FOR FURTHER INFORMATION CONTACT: 

Vanessa Lee, MPH, Designated Federal 

Official, Maternal and Child Health 

Bureau, HRSA, 5600 Fishers Lane, 

Room 18N84, Rockville, Maryland 

20857; 301–443–0543; or VLee1@

hrsa.gov. 

SUPPLEMENTARY INFORMATION: ACIMM is 

authorized by section 222 of the Public 

Health Service Act (42 U.S.C. 217a), as 

amended. The Committee is governed 

by provisions of Public Law 92–463, as 

amended (5 U.S.C. 10), which sets forth 

standards for the formation and use of 

Advisory Committees. ACIMM advises 

the Secretary of Health and Human 

Services on department activities, 

partnerships, policies, and programs 

directed at reducing infant mortality, 

maternal mortality and severe maternal 

morbidity, and improving the health 

status of infants and women before, 

during, and after pregnancy. The 

Committee provides advice on how best 

to coordinate Federal, State, local, 

Tribal, and Territorial governmental 

efforts designed to improve infant 

mortality, related adverse birth 

outcomes, and maternal health, as well 

as influence similar efforts in the private 

and voluntary sectors. The Committee 

provides guidance and 

recommendations on the policies, 

programs, and resources required to 

address the disparities and inequities in 

infant mortality, related adverse birth 

outcomes and maternal health 

outcomes, including maternal mortality 

and severe maternal morbidity. With its 

focus on underlying causes of the 

disparities and inequities seen in birth 

outcomes for women and infants, the 

Committee advises the Secretary of 

Health and Human Services on the 

health, social, economic, and 

environmental factors contributing to 

the inequities and proposes structural, 

policy and/or systems level changes. 

The charter renewal for ACIMM was 

approved on September 8, 2023. The 

filing date is September 30, 2023. 

Renewal of the ACIMM charter gives 

authorization for the committee to 

operate until September 30, 2025. 

A copy of the ACIMM charter is 

available on the ACIMM website at 

https://www.hrsa.gov/advisorycommittees/infant-mortality/index.html. 

A copy of the charter also can be 

obtained by accessing the FACA 

database that is maintained by the 

Committee Management Secretariat 

under the General Services 

Administration. The website address for 

the FACA database is http://

www.facadatabase.gov/. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2023–21716 Filed 9–29–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group, Therapeutic Development and 

Preclinical Studies Study Section. 

Date: October 25–26, 2023. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW, 

Washington, DC 20015. 

Contact Person: Richard D Schneiderman, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4138, 

Bethesda, MD 20817, 301–402–3995, 

richard.schneiderman@nih.gov. 

Name of Committee: Interdisciplinary 

Molecular Sciences and Training Integrated 

Review Group, Cellular and Molecular 

Technologies Study Section. 

Date: October 25–26, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Tatiana V Cohen, Ph.D., 

Scientific Review Officer, Center for 


lotter on DSK11XQN23PROD with NOTICES1
67768 Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5213, 

Bethesda, MD 20892, 301–455–2364, 

tatiana.cohen@nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group, Integrative Myocardial Physiology/ 

Pathophysiology A Study Section. 

Date: October 25–26, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Abdelouahab Aitouche, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4222, 

MSC 7814, Bethesda, MD 20892, 301–435– 

2365, aitouchea@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology A Integrated Review Group, 

Molecular and Cellular Biology of Virus 

Infection Study Section. 

Date: October 25–26, 2023. 

Time: 9:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Kenneth M Izumi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, MSC 7808, 

Bethesda, MD 20892, (301) 496–6980, 

izumikm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel, Member 

Conflict: Topics in Biobehavioral Processes. 

Date: October 25, 2023. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Courtney M Pollack, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 594–3671, courtney.pollack@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Fellowships: Sensory and Motor 

Neurosciences, Cognition and Perception. 

Date: October 25–26, 2023. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: John N Stabley, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 594–0566, stableyjn@

csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Special 

Topics: Brain Imaging, Vision, 

Bioengineering and Low Vision Technology 

Development. 

Date: October 26–27, 2023. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Capitol, 550 C Street, 

SW Washington, DC 20024. 

Contact Person: Susan Gillmor, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (240) 762–3076, susan.gillmor@

nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group, Emerging Imaging 

Technologies and Applications Study 

Section. 

Date: October 26–27, 2023. 

Time: 8:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: North Bethesda Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Zheng Li, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, 301–594–3385, 

zheng.li3@nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group, Chemical Synthesis and 

Biosynthesis Study Section. 

Date: October 26–27, 2023. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Shan Wang, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 496–4390, shan.wang@nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology A Integrated Review Group, 

Cellular and Molecular Immunology—A 

Study Section. 

Date: October 26–27, 2023. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Blvd., Gaithersburg, MD 20878. 

Contact Person: Mohammad Samiul Alam, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 809D, 

Bethesda, MD 20892, (301) 435–1199, 

alammos@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology A Integrated Review Group 

Cellular and Molecular Immunology—B 

Study Section 

Date: October 26–27, 2023 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications 

Place: The William F. Bolger Center 9600 

Newbridge Drive Potomac, MD 20854 

Contact Person: Liying Guo, Ph.D. 

Scientific Review Officer Center for Scientific 

Review National Institutes of Health 6701 

Rockledge Drive, Room 4198, MSC 7812 

Bethesda, MD 20892 (301) 827–7728 lguo@

mail.nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology B Integrated Review Group 

Hypersensitivity, Autoimmune, and Immunemediated Diseases Study Section. 

Date: October 26–27, 2023. 

Time: 8:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza National Airport, 1480 

Crystal Drive, Arlington, VA 22202. 

Contact Person: Xinrui Li, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, (301) 594–2084, 

xinrui.li@nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, 

Pathophysiology of Obesity and Metabolic 

Disease Study Section. 

Date: October 26–27, 2023. 

Time: 8:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Alexandria, Old 

Town, 1900 Diagonal Road, Alexandria, VA 

22314. 

Contact Person: Heather Marie Brockway, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 813H, 

Bethesda, MD 20892, (301) 594–5228, 

brockwayhm@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group 

Hepatobiliary Pathophysiology Study 

Section. 

Date: October 26–27, 2023. 

Time: 9:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Jianxin Hu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2156, 

Bethesda, MD 20892, 301–827–4417, 

jianxinh@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group, Neuronal Communications 

Study Section. 

Date: October 26–27, 2023. 

Time: 9:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Prithi Rajan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 435–1042, prithi.rajan@nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group, Imaging 

Technology Development Study Section. 

Date: October 26–27, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices 67769 

Place: National Institutes of Health 

Rockledge II, 6701 Rockledge Drive Bethesda, 

MD 20892, (Virtual Meeting). 

Contact Person: Guo Feng Xu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5122, 

MSC 7854, Bethesda, MD 20892, (301) 237– 

9870, xuguofen@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group, Maximizing 

Investigators’ Research Award—D Study 

Section. 

Date: October 26–27, 2023. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Linda MacArthur, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4187, 

Bethesda, MD 20892, 301–537–9986, 

macarthurlh@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group, Acute Neural Injury and Epilepsy 

Study Section. 

Date: October 26–27, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Paula Elyse Schauwecker, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5201, 

Bethesda, MD 20892, 301–760–8207, 

schauweckerpe@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group, 

Organization and Delivery of Health Services 

Study Section. 

Date: October 26–27, 2023. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Catherine Hadeler 

Maulsby, Ph.D., MPH Scientific Review 

Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, (301) 435–1266, 

maulsbych@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group, Motor Function, Speech and 

Rehabilitation Study Section. 

Date: October 26–27, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Stephanie Nagle Emmens, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 594–6604, nagleemmenssc@

csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 26, 2023. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21590 Filed 9–29–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center For Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Medical Imaging Investigations. 

Date: November 6, 2023. 

Time: 9 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Khalid Masood, Ph.D., 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5120, 

MSC 7854, Bethesda, MD 20892, 301–435– 

2392, masoodk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Biobehavioral Processes. 

Date: November 6–7, 2023. 

Time: 10 a.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jeanne M. McCaffery, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, 301–594–3854, 

jeanne.mccaffery@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Topics in Vaccines Against 

Infectious Diseases and Vector-Borne and 

Zoonotic Diseases. 

Date: November 6, 2023. 

Time: 10 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Shinako Takada, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–827–5997, shinako.takada@

nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

Cardiovascular and Respiratory Diseases 

Study Section. 

Date: November 7–8, 2023. 

Time: 8 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Hybrid Meeting). 

Contact Person: Mohammed F.A. 

Elfaramawi, Ph.D., MD, Scientific Review 

Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 1007F, Bethesda, MD 20892, 

(301) 480–1142, elfaramawimf@csr.nih.gov. 

Name of Committee: Applied Immunology 

and Disease Control Integrated Review 

Group; Drug Discovery and Molecular 

Pharmacology A Study Section. 

Date: November 7–8, 2023. 

Time: 8:30 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree by Hilton McLean 

Tysons, 1960 Chain Bridge Road, Mclean, VA 

22102. 

Contact Person: Bidyottam Mittra, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, Bethesda, MD 20892, (301) 435–0000, 

bidyottam.mittra@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Oncology. 

Date: November 7–8, 2023. 

Time: 10 a.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Nywana Sizemore, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6189, 

MSC 7804, Bethesda, MD 20892, 301–408– 

9916, sizemoren@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Aging, Infection, and Cellular 

Signaling. 

Date: November 7, 2023. 

Time: 11 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 


lotter on DSK11XQN23PROD with NOTICES1